Literature DB >> 8611457

Fibrinogen Lincoln: a new truncated alpha chain variant with delayed clotting.

H J Ridgway1, S O Brennan, S Gibbons, P M George.   

Abstract

A patient referred for preoperative investigation of prolonged bleeding and easy bruising was found to have increased thrombin and reptilase times; however, the thrombin catalysed release of fibrinopeptides A and B was normal. Analysis of five other family members, spanning three generations, indicated that three had a similar defect and suggested autosomal dominant inheritance. Non-reducing SDS-PAGE of purified fibrinogen from affected individuals showed that the 340 kD form of their fibrinogen ran as a doublet. SSCP (single-stranded conformational polymorphism) analysis of exon 5 of the A alpha gene, which encodes the C-terminal half of the chain, confirmed the presence of a mutation. Cycle sequencing of PCR amplified DNA revealed a 13 base pair deletion (nt 4758-4770), resulting in a frame-shift at Ala 475, which translates as four new amino acids before terminating at a new stop codon (-476His-Cys-Leu-Ala-Stop). The presence of a circulating truncated A alpha chain was confirmed when SDS-PAGE gels were probed with an alpha chain specific antisera; which showed that the variant A alpha chain comigrated with gamma chains. The truncation results in a variant A alpha chain with a deletion of 131 amino acids (480-610), and four new amino acids at the C-terminal.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611457     DOI: 10.1046/j.1365-2141.1996.4681007.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis.

Authors:  Jean-Philippe Collet; Jennifer L Moen; Yuri I Veklich; Oleg V Gorkun; Susan T Lord; Gilles Montalescot; John W Weisel
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

2.  Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other.

Authors:  Rustem I Litvinov; Sergiy Yakovlev; Galina Tsurupa; Oleg V Gorkun; Leonid Medved; John W Weisel
Journal:  Biochemistry       Date:  2007-07-13       Impact factor: 3.162

3.  Hypodysfibrinogenemia causing mild bleeding and thrombotic complications in a compound heterozygote of AalphaIVS4+1G>T mutation and Aalpha4841delC truncation (Aalpha(Perth)).

Authors:  Asier Jayo; Erin Arnold; Consuelo González-Manchón; David Green; Susan T Lord
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

4.  Hypofibrinogenemia with preserved hemostasis and protection from thrombosis in mice with an Fga truncation mutation.

Authors:  Woosuk S Hur; David S Paul; Emma G Bouck; Oscar A Negrón; Jean-Marie Mwiza; Lauren G Poole; Holly M Cline-Fedewa; Emily G Clark; Lih Jiin Juang; Jerry Leung; Christian J Kastrup; Tatiana P Ugarova; Alisa S Wolberg; James P Luyendyk; Wolfgang Bergmeier; Matthew J Flick
Journal:  Blood       Date:  2022-03-03       Impact factor: 22.113

Review 5.  Human Fibrinogen: Molecular and Genetic Aspects of Congenital Disorders.

Authors:  Giovanni Luca Tiscia; Maurizio Margaglione
Journal:  Int J Mol Sci       Date:  2018-05-29       Impact factor: 5.923

Review 6.  Fibrinogen αC domain: Its importance in physiopathology.

Authors:  Jeannette Soria; Shahsoltan Mirshahi; Sam Qiumars Mirshahi; Remi Varin; Linda L Pritchard; Claudine Soria; Massoud Mirshahi
Journal:  Res Pract Thromb Haemost       Date:  2019-02-15

7.  Fibrinogen αC-subregions critically contribute blood clot fibre growth, mechanical stability, and resistance to fibrinolysis.

Authors:  Helen R McPherson; Cedric Duval; Stephen R Baker; Matthew S Hindle; Lih T Cheah; Nathan L Asquith; Marco M Domingues; Victoria C Ridger; Simon DA Connell; Khalid M Naseem; Helen Philippou; Ramzi A Ajjan; Robert As Ariëns
Journal:  Elife       Date:  2021-10-11       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.